Key result
Polyelectrolyte complexes of lower molecular weight sodium dextran sulfate and those prepared by adding sodium dextran sulfate to chitosan exhibited greater in vitro clot-inhibiting properties.
The clot-inhibiting properties of sodium dextran sulfate-chitosan complexes depend on preparation conditions, suggesting potential for developing ordered antithrombogenic materials.
Preparation-dependent clot inhibition in dextran sulfate-chitosan complexes may guide biomaterial tuning; leaves open in vivo validation before clinical vascular use.
The solution of charged sodium dextran sulfate (molecular weight 6000) co‐reacted with that of oppositely charged chitosan to form a water‐insoluble hydrous complex, whose clot‐inhibiting property was sensitive to such reaction conditions as the order of mixing, the kind of acid species used for the adjustment of pH, and the concentration of hydrogen ion at which the preparation of polyelectrolyte complex was carried out, although all the polyelectrolyte complexes were prepared from the same starting materials. In order to clarify the relationship between the molecular conformation of the polyelectrolyte complex and its clot‐inhibiting property, ir spectroscopic studies, in vitro blood‐clotting tests, color reaction with toluidine blue, elemental analyses, and so on, were performed. Consequently, it was suggested that the polyelectrolyte complexes consisting of sodium dextran sulfate of lower molecular weight are more clot‐inhibiting than those with higher molecular weight. It was also found that polyelectrolyte complexes prepared under the mixing order of sodium dextran sulfate solution added to chitosan solution are also more clot‐inhibiting than those prepared under the reverse mixing order, chitosan solution added to sodium dextran sulfate solution. Furthermore, it has become apparent that the anticlotting polyelectrolyte complexes have some characteristic ir absorption bands, and that they displayed color reaction with toluidine blue. A new possibility may be anticipated from our experimental results, providing important information relating to realizing a functional polymer, antithrombogenic material, whose property may be ordered.
No takes yet. Share an insight, caveat, or question.
Fukuda et al. (1978) studied this question. Polyelectrolyte complexes of sodium dextran sulfate with chitosan vs. Different mixing orders and molecular weights was evaluated on In vitro clot-inhibiting property. Polyelectrolyte complexes of lower molecular weight sodium dextran sulfate and those prepared by adding sodium dextran sulfate to chitosan exhibited greater in vitro clot-inhibiting properties.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: